Category: Life Sciences
Global Life Sciences
-
Global Oral Rehydration Solution Market Research Report 2024
... of 5.34% during the forecast period 2024-2030. North American market for Oral Rehydration Solution is estimated to increase from $ 275.7 million in 2023 to reach $ 384.35 million by 2030, at a CAGR of ... Read More
-
Global Electric Cannabis Grinder Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... million in 2023 and is forecast to a readjusted size of USD 2066 million by 2030 with a CAGR of 7.2% during review period. Legalization of cannabis in several countries over past few years have ... Read More
-
3D Cell Culture Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
... valued at USD 2.06 billion in 2022, and the market is now projected to grow from USD 2.29 billion in 2023 to USD 4.96 billion by 2030, exhibiting a CAGR of 11.7% during the forecast ... Read More
-
Global Peripheral Drug-Coated Balloon Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... million in 2023 and is forecast to a readjusted size of USD 1380.6 million by 2030 with a CAGR of 6.5% during review period. Drug-coated balloons (DCB) have been introduced to improve patency rates following ... Read More
-
Medical Transcription Software Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
... valued at USD 2.24 billion in 2023, and the market is now projected to grow from USD 2.55 billion in 2024 to USD 8.41 billion by 2032, exhibiting a CAGR of 16.1% during the forecast ... Read More
-
Ileostomy
... of 7.5% over the analysis period 2023-2030. End Ileostomy Procedure, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$1.5 Billion by the end of the analysis ... Read More
-
LED Video Walls
... by 2030, growing at a CAGR of 6.9% over the analysis period 2023-2030. Indoor Deployment, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$2.0 Billion by ... Read More
-
Monopolar Electrosurgery Devices
... by 2030, growing at a CAGR of 4.2% over the analysis period 2023-2030. Hand Instruments, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$1.2 Billion by ... Read More
-
Non-Surgical Skin Tightening Devices
... reach US$741.7 Million by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. Laser Based Devices, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and ... Read More
-
Atomic Force Microscopy
... by 2030, growing at a CAGR of 5.7% over the analysis period 2023-2030. Industrial Grade Atomic Force Microscopy, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach ... Read More
-
Patient Monitoring Devices
... by 2030, growing at a CAGR of 7.4% over the analysis period 2023-2030. Blood Glucose Monitoring Devices, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$23.2 ... Read More
-
Probiotics Dietary Supplements
... by 2030, growing at a CAGR of 5.8% over the analysis period 2023-2030. Capsules Form, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$4.2 Billion by ... Read More
-
Restorative Dentistry
... at a CAGR of 8.3% over the analysis period 2023-2030. Restorative Materials, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$19.4 Billion by the end of ... Read More
-
Veterinary Electrosurgery
... at a CAGR of 8.4% over the analysis period 2023-2030. Bipolar Electrosurgery Instruments, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$74.4 Million by the end ... Read More
-
Veterinary Pain Management
... by 2030, growing at a CAGR of 7.7% over the analysis period 2023-2030. Pain Management Drugs, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$2.1 Billion ... Read More
-
Protein Sequencing
... at a CAGR of 2.9% over the analysis period 2023-2030. Mass Spectrometry Technology, one of the segments analyzed in the report, is expected to record a 2.7% CAGR and reach US$973.5 Million by the end ... Read More
-
Veterinary X-ray
... at a CAGR of 6.4% over the analysis period 2023-2030. Computed Radiography Technology, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$360.6 Million by the end ... Read More
-
Sodium Alginate
... at a CAGR of 4.9% over the analysis period 2023-2030. Stabilizers Application, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$137.4 Million by the end of ... Read More
-
Antisense and RNAi Therapeutics
... reach US$3.6 Billion by 2030, growing at a CAGR of 8.1% over the analysis period 2023-2030. Antisense RNA Technology, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and ... Read More
-
Surgical Drapes and Gowns
... reach US$5.5 Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2023-2030. Surgical Drapes, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach ... Read More
-
Pre-Owned Medical Devices
... by 2030, growing at a CAGR of 7.7% over the analysis period 2023-2030. Pre-Owned CT Machines, one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach US$3.6 Billion ... Read More
-
Biochemical Reagents
... at a CAGR of 8.7% over the analysis period 2023-2030. PCR Reagent Kits, one of the segments analyzed in the report, is expected to record a 11.0% CAGR and reach US$6.3 Billion by the end ... Read More
-
Bio-MEMS
... of 16.8% over the analysis period 2023-2030. Microfluidic Chips, one of the segments analyzed in the report, is expected to record a 17.2% CAGR and reach US$27.4 Billion by the end of the analysis period. ... Read More
-
Biopharmaceutical Logistics
... at a CAGR of 4.8% over the analysis period 2023-2030. Cold Chain Logistics, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$37.9 Billion by the end ... Read More
-
Biopharmaceutical Fermentation Systems
... by 2030, growing at a CAGR of 4.5% over the analysis period 2023-2030. Upstream Products, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach US$6.5 Billion by ... Read More
Research Assistance
